Renal complications of sickle cell disease: Managing for optimal outcomes

Pediatric Drugs

Volumn 4, Issue 1, 2002, Pages 29-36

  Feltran, L D S ^a   Carvalhaes, J T D A ^a   Sesso, R ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIINFLAMMATORY AGENT; BICARBONATE; CODEINE; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; HYDROXYUREA; INDOMETACIN; POTASSIUM; PREDNISONE; RECOMBINANT ERYTHROPOIETIN;

ALKALINIZATION; FLUID THERAPY; GLOMERULOPATHY; HEMATURIA; HEMODIALYSIS; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; KIDNEY TUBULE DISORDER; NEPHROTIC SYNDROME; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SICKLE CELL ANEMIA;

EID: 0036186867     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128072-200204010-00004     Document Type: Review

References (58)

1. Sickle cell nephropathy
2. Renal abnormalities in sickle cell disease
3. Haematuria and sickle cell disease: A report of 12 cases and review of the literature
4. Sickle cell nephropathy
5. Nature of concentrating defect in sickle cell nephropathy
6. The management of hematuria associated with sickle haemoglobinopathy
7. Urographic changes in homozygous sickle cell disease
8. Renal medullary carcinoma: Sonographic, computed tomography, magnetic resonance and angiographic findings
9. Renal medullary carcinoma: The seventh sickle cell nephropathy
10. Renal medullary carcinoma: A potential sickle cell nephropathy of children and adolescents
11. The kidney and hemoglobin
12. Three-year follow-up of hydroxyurea treatment in severely ill children with sickle cell disease
13. Treatment of sickle cell anemia with hydroxyurea and erythropoietin
14. Hydroxyurea promotes the reduction of spontaneous BFU-e to normal levels in SS and S/beta thalassemic patients
15. A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia
16. Renal abnormalities in sickle cell disease
17. Treatment of sickle cell trait hematuria with oral urea
18. Complications of therapy with epsilon aminocaproic acid
19. The use of epsilon aminocaproic acid in the control of hematuria associated with hemoglobinopathies
20. Protracted, gross hematuria in sickle cell trait: Response to multiple doses of 1-desamino-8-D-arginine vasopressin
21. Massive gross hematuria in a sickle cell trait patient with renal papillary necrosis
22. Renal dysfunction in patients with sickle cell anemia or sickle cell trait
23. Effects of nonsteroidal antiinflammatory drugs on renal function in sickle cell anemia
24. Pathophysiologic mechanisms of abnormal collecting duct function
25. The kidney in sickle cell anemia
26. Sickle cell nephropathy: New insights into its pathophysiology
27. Renal abnormalities in sickle cell disease
28. Microangiopathic glomerulopathy in children with sickle cell anemia
29. Comparison of effect of an anti-inflammatory drug and a narcotic analgesic on renal function in sickle cell anemia
30. The influence of indomethacin on renal acidification in normal subjects and in patients with sickle cell anemia
31. Sickle cell nephropathy during the postpartum period in a patient with SLE
32. Chronic renal failure in sickle cell disease: Risk factors, clinical course, and mortality
33. Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme
34. Prevalence of microalbuminuria in children with sickle cell disease
35. Microalbuminuria in sickle cell disease
36. Sickle cell anemia causes a distinct pattern of glomerular dysfunction
37. Renal transplantation in end-stage sickle cell nephropathy
38. Recurrent sickle cell nephropathy in a transplanted kidney
39. Renal transplantation in patients with sickle cell nephropathy
40. Erythropoietin for the anemia of renal failure in sickle cell disease
41. Erythropoietin in anemia of renal failure in sickle cell disease
42. Sickle cell trait: Possible contributory cause of renal allograft failure
43. End stage renal disease in sickle cell disease: Future directions
44. Prevalence and clinical correlates of glomerulopathy in children with sickle cell disease
45. Nephropathy associated with sickle cell anemia: An autologous immune complex nephritis II: Clinic pathologic studies in seven patients
46. Urinary prostaglandins in sickle cell nephropathy: A defect in 9-ketoreductase activity?
47. Renal nitric oxide synthase in transgenic sickle cell mice
48. Inhibition of nitric oxide synthase ameliorates cellular injury in sickle cell mouse kidneys
49. Enalapril reduces the albuminuria of patients with sickle cell disease
50. Glomerular lesions in mice transgenic for growth hormone and glomerular size and mesangial sclerosis
51. Eicosanoids in sickle cell disease: Potential relevance of 12(s)-hydroxy-5,8,10,14-eicosatetraenoic acid to the pathophysiology of vaso-occlusion
52. Sickle red blood cells stimulate endothelial cell production of eicosanoids and diacylglycerol
53. Blood pressure in acute vaso-occlusive crises of sickle cell disease
54. Bone marrow transplantation for sickle cell anemia
55. Exertional collapse and sudden death associated with sickle cell trait
56. Acute multiorgan failure syndrome: A potentially catastrophic complication of severe sickle cell pain episode
57. Acute renal failure in sickle cell disease